Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial Infarction REPLY

被引：0
|
作者：
Pfeffer, Marc A. [1 ]
Jering, Karola S. [1 ]
Braunwald, Eugene [1 ]
机构：
[1] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2022年 / 386卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：603 / 603
页数：1
相关论文
共 50 条
  • [41] Angiotensin receptor-neprilysin inhibitors: Comprehensive review and implications in hypertension treatment
    Koichi Yamamoto
    Hiromi Rakugi
    [J]. Hypertension Research, 2021, 44 : 1239 - 1250
  • [42] Angiotensin receptor-neprilysin inhibitors: Comprehensive review and implications in hypertension treatment
    Yamamoto, Koichi
    Rakugi, Hiromi
    [J]. HYPERTENSION RESEARCH, 2021, 44 (10) : 1239 - 1250
  • [43] Angiotensin receptor blockers in acute myocardial infarction
    Salam, AM
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2004, 13 (04) : 427 - 430
  • [44] Safety and Tolerability of Angiotensin Receptor-Neprilysin Inhibitor Initiation in High-Risk Acute Myocardial Infarction Relative to Care Setting: A Subgroup Analysis of the PARADISE-MI Trial
    De Pasquale, Carmine G.
    Claggett, Brian
    Jering, Karola
    McMurray, John J. V.
    Mann, Douglas
    Miao, Zi Michael
    Granger, Christopher B.
    Kober, Lars
    Maggioni, Aldo P.
    Rouleau, Jean-Lucien
    Solomon, Scott D.
    Steg, Philippe Gabriel
    van der Meer, Peter
    Braunwald, Eugene
    Pfeffer, Marc A.
    [J]. CIRCULATION-HEART FAILURE, 2024, 17 (07)
  • [45] Impact of angiotensin receptor-neprilysin inhibition on vascular function in heart failure with reduced ejection fraction: A pilot study
    Nathaniel, Sangeetha
    McGinty, Shane
    Witman, Melissa A. H.
    Edwards, David G.
    Farquhar, William B.
    Hosmane, Vinay
    Wenner, Megan M.
    [J]. PHYSIOLOGICAL REPORTS, 2022, 10 (05):
  • [46] Angiotensin Receptor-Neprilysin Inhibition (Sacubitril/ Valsartan) Reduces Structural Arterial Stiffness in Middle-Aged Mice
    Schellinger, Isabel N.
    Dannert, Angelika
    Hoffmann, Annet
    Chodisetti, Giriprakash
    Mattern, Karin
    Petzold, Anne
    Kloeting, Nora
    Schuster, Andreas
    Wagenhaeuser, Markus U.
    Emrich, Fabian
    Stumvoll, Michael
    Hasenfuss, Gerd
    Raaz, Uwe
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (04):
  • [47] Crossing the chasm: caution for use of angiotensin receptor-neprilysin inhibition in patients with cardiogenic shock-a case report
    Almazroa, Loai
    Mihajlovic, Vesna
    Lawler, Patrick R.
    Luk, Adriana
    [J]. EUROPEAN HEART JOURNAL-CASE REPORTS, 2020, 4 (06)
  • [48] In-Hospital Initiation of Angiotensin Receptor-Neprilysin Inhibitors-The Time Is Now
    Srivastava, Pratyaksh K.
    Fonarow, Gregg C.
    [J]. JAMA CARDIOLOGY, 2019, 4 (03) : 195 - 196
  • [49] CLINICAL BENEFITS OF ANGIOTENSIN RECEPTOR-NEPRILYSIN INHIBITOR IN ADULTS WITH CONGENITAL HEART DISEASE
    Andi, Kartik
    Egbe, Alexander C.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 1547 - 1547
  • [50] First-in-Class Composite Angiotensin Receptor-Neprilysin Inhibitors (ARNI) in Practice
    Barghash, M. H.
    Desai, A. S.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 102 (02) : 265 - 268
12345